{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:31:21Z","timestamp":1787884281047,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Knee osteoarthritis (OA) is a debilitating condition affecting human body biomechanics and quality of life. Current standard care for knee OA leads to trivial improvement and entails multiple adverse effects or complications. Recently, investigational cell therapies injected intra-articularly, such as bone marrow aspirate concentrate (BMAC) and platelet-rich plasma (PRP), have shown safety and therapeutic potency providing patients with pain relief. In the current retrospective comparative study, we investigated the differences in pain and functional improvements in patients with symptomatic knee OA receiving intra-articular injections of BMAC vs PRP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Pain and functionality scores were measured at baseline and at different time points post-injection over 12\u2009months, using 3 self-administered, clinically validated questionnaires: the visual analogue scale (VAS) for assessing pain intensity, the knee injury and osteoarthritis outcome score (KOOS) for evaluating functionality and knee-related quality of life, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) for evaluating physical function. The repeated-measures general linear model with Sidak test for pairwise comparisons was used to investigate the influence of the treatment on the score evolution within groups (between baseline and each time point) and between groups (overall).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The BMAC group (<jats:italic>n<\/jats:italic>\u2009=\u200926 knees) significantly improved in VAS, KOOS, and WOMAC scores between baseline and 12\u2009months (57.4, 75.88, and 73.95% mean score improvement, respectively). In contrast, the PRP group (<jats:italic>n<\/jats:italic>\u2009=\u200913 knees) witnessed nonsignificant improvement in all scores. BMAC, in comparison to PRP, induced significant improvement in outcomes by 29.38% on the VAS scale, 53.89% on the KOOS scale, and 51.71% on the WOMAC scale (<jats:italic>P<\/jats:italic>\u2009&lt;\u2009.002, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.01, <jats:italic>P<\/jats:italic>\u2009&lt;\u2009.011, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Intra-articular autologous BMAC injections are safe, effective in treating pain, and ameliorate functionality in patients with symptomatic knee OA to a greater extent than PRP injections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                <jats:p>Intra-articular autologous BMAC therapy is safe and provides more relief to patients with symptomatic knee osteoarthritis compared to PRP therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04910-5","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:02:57Z","timestamp":1641229377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study"],"prefix":"10.1186","volume":"23","author":[{"given":"Abed El-Hakim","family":"El-Kadiry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lumbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Salame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutih","family":"Rafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riam","family":"Shammaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"4910_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/annrheumdis-2014-205327","volume":"73","author":"K Storheim","year":"2014","unstructured":"Storheim K, Zwart JA. Musculoskeletal disorders and the global burden of disease study. Ann Rheum Dis. 2014;73:949\u201350.","journal-title":"Ann Rheum Dis"},{"key":"4910_CR2","volume-title":"Osteoarthritis in Canada","author":"Public Health Agency of Canada","year":"2020","unstructured":"Public Health Agency of Canada. Osteoarthritis in Canada. 2020. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/osteoarthritis.html. Accessed 5 Jan 2021."},{"key":"4910_CR3","volume-title":"Reducing the impact of OA: a report on the prevention and effective management in Canada","author":"A Davis","year":"2014","unstructured":"Davis A, Badley E, Mcglasson R, Alleyne Bsc J. Reducing the impact of OA: a report on the prevention and effective management in Canada. 2014. http:\/\/boneandjointcanada.com\/wp-content\/uploads\/2014\/05\/BJC-OA-Meeting-Report-Final.pdf. Accessed 5 Jan 2021."},{"key":"4910_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/pmrj.12066","volume":"11","author":"DG Manlapaz","year":"2019","unstructured":"Manlapaz DG, Sole G, Jayakaran P, Chapple CM. Risk factors for falls in adults with knee osteoarthritis: a systematic review. PM R. 2019;11:745\u201357.","journal-title":"PM R"},{"key":"4910_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40520-018-1077-8","volume":"31","author":"J Martel-Pelletier","year":"2019","unstructured":"Martel-Pelletier J, Maheu E, Pelletier JP, Alekseeva L, Mkinsi O, Branco J, et al. A new decision tree for diagnosis of osteoarthritis in primary care: international consensus of experts. Aging Clin Exp Res. 2019;31:19\u201330. https:\/\/doi.org\/10.1007\/s40520-018-1077-8.","journal-title":"Aging Clin Exp Res"},{"key":"4910_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22:363\u201388.","journal-title":"Osteoarthr Cartil"},{"key":"4910_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1759720X16642405","volume":"8","author":"P Wehling","year":"2016","unstructured":"Wehling P, Moser C, Maixner W. How does surgery compare with advanced intra-articular therapies in knee osteoarthritis: current thoughts. Ther Adv Musculoskelet Dis. 2016;8:72\u201385. https:\/\/doi.org\/10.1177\/1759720X16642405.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4910_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7835","volume":"350","author":"LS Lohmander","year":"2015","unstructured":"Lohmander LS, Roos EM. The evidence base for orthopaedics and sports medicine. BMJ. 2015;350:g7835. https:\/\/doi.org\/10.1136\/bmj.g7835.","journal-title":"BMJ."},{"key":"4910_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3253","volume":"348","author":"K Wartolowska","year":"2014","unstructured":"Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJF, Rombach I, et al. Use of placebo controls in the evaluation of surgery: systematic review. BMJ. 2014;348:g3253. https:\/\/doi.org\/10.1136\/bmj.g3253.","journal-title":"BMJ."},{"key":"4910_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1634","volume":"32","author":"CH Jo","year":"2014","unstructured":"Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32:1254\u201366. https:\/\/doi.org\/10.1002\/stem.1634.","journal-title":"Stem Cells"},{"key":"4910_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3810\/psm.2014.09.2076","volume":"42","author":"P Jayabalan","year":"2014","unstructured":"Jayabalan P, Hagerty S, Cortazzo MH. The use of platelet-rich plasma for the treatment of osteoarthritis. Phys Sportsmed. 2014;42:53\u201362. https:\/\/doi.org\/10.3810\/psm.2014.09.2076.","journal-title":"Phys Sportsmed"},{"key":"4910_CR12","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s11999-011-1857-3","volume":"469","author":"LA Fortier","year":"2011","unstructured":"Fortier LA, Barker JU, Strauss EJ, McCarrel TM, Cole BJ. The role of growth factors in cartilage repair. Clin Orthop Relat Res. 2011;469:2706\u201315. https:\/\/doi.org\/10.1007\/s11999-011-1857-3.","journal-title":"Clin Orthop Relat Res"},{"key":"4910_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/bjsports-2014-094036","volume":"49","author":"ABM Laudy","year":"2015","unstructured":"Laudy ABM, Bakker EWP, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med. 2015;49:657\u201372. https:\/\/doi.org\/10.1136\/bjsports-2014-094036.","journal-title":"Br J Sports Med"},{"key":"4910_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12178-018-9524-x","volume":"11","author":"CS Cook","year":"2018","unstructured":"Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Curr Rev Musculoskelet Med. 2018;11:583\u201392. https:\/\/doi.org\/10.1007\/s12178-018-9524-x.","journal-title":"Curr Rev Musculoskelet Med"},{"key":"4910_CR15","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/ijms21093224","volume":"21","author":"GB Kim","year":"2020","unstructured":"Kim GB, Seo MS, Park WT, Lee GW. Bone marrow aspirate concentrate: its uses in osteoarthritis. Int J Mol Sci. 2020;21:3224. https:\/\/doi.org\/10.3390\/ijms21093224.","journal-title":"Int J Mol Sci"},{"key":"4910_CR16","doi-asserted-by":"publisher","unstructured":"Shammaa R, El-Kadiry AE, Abusarah J, Rafei M. Mesenchymal stem cells beyond regenerative medicine. Front cell. Dev Biol.\u00a02020;8:72.\u00a0https:\/\/doi.org\/10.3389\/fcell.2020.00072.","DOI":"10.3389\/fcell.2020.00072"},{"key":"4910_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fbioe.2020.00202","volume":"8","author":"D Kouroupis","year":"2020","unstructured":"Kouroupis D, Ahari AF, Correa D, Shammaa R. Intralesional injection of bone marrow aspirate concentrate for the treatment of osteonecrosis of the knee secondary to systemic lupus Erythematosus: a case report. Front Bioeng Biotechnol. 2020;8:202. https:\/\/doi.org\/10.3389\/fbioe.2020.00202.","journal-title":"Front Bioeng Biotechnol"},{"key":"4910_CR18","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s11033-020-05428-0","volume":"47","author":"C Eder","year":"2020","unstructured":"Eder C, Schmidt-Bleek K, Geissler S, Sass FA, Maleitzke T, Pumberger M, et al. Mesenchymal stromal cell and bone marrow concentrate therapies for musculoskeletal indications: a concise review of current literature. Mol Biol Rep. 2020;47:4789\u2013814. https:\/\/doi.org\/10.1007\/s11033-020-05428-0.","journal-title":"Mol Biol Rep"},{"key":"4910_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.622573","volume":"8","author":"AEH El Kadiry","year":"2021","unstructured":"El Kadiry AEH, Lumbao C, Rafei M, Shammaa R. Autologous BMAC therapy improves spinal degenerative joint disease in lower back pain patients. Front Med. 2021;8:622573.","journal-title":"Front Med"},{"key":"4910_CR20","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00590-013-1393-9","volume":"24","author":"KJ Do","year":"2014","unstructured":"Do KJ, Lee GW, Jung GH, Kim CK, Kim T, Park JH, et al. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol. 2014;24:1505\u201311. https:\/\/doi.org\/10.1007\/s00590-013-1393-9.","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"4910_CR21","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s00264-015-2785-8","volume":"39","author":"P Xia","year":"2015","unstructured":"Xia P, Wang X, Lin Q, Li X. Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop. 2015;39:2363\u201372. https:\/\/doi.org\/10.1007\/s00264-015-2785-8.","journal-title":"Int Orthop"},{"key":"4910_CR22","doi-asserted-by":"publisher","first-page":"e40833","DOI":"10.1371\/journal.pone.0040833","volume":"7","author":"W Zhong","year":"2012","unstructured":"Zhong W, Sumita Y, Ohba S, Kawasaki T, Nagai K, Ma G, et al. In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One. 2012;7:e40833. https:\/\/doi.org\/10.1371\/journal.pone.0040833.","journal-title":"PLoS One"},{"key":"4910_CR23","doi-asserted-by":"publisher","first-page":"117954412093108","DOI":"10.1177\/1179544120931086","volume":"13","author":"E Estrada","year":"2020","unstructured":"Estrada E, D\u00e9cima JL, Rodr\u00edguez M, Di Tomaso M, Roberti J. Patient-reported outcomes after platelet-rich plasma, bone marrow aspirate, and adipose-derived mesenchymal stem cell injections for symptomatic knee osteoarthritis. Clin Med Insights Arthr Musculoskelet Disord. 2020;13:1179544120931086. https:\/\/doi.org\/10.1177\/1179544120931086.","journal-title":"Clin Med Insights Arthr Musculoskelet Disord"},{"key":"4910_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/17453674.2017.1368899","volume":"88","author":"G Moatshe","year":"2017","unstructured":"Moatshe G, Morris ER, Cinque ME, Pascual-Garrido C, Chahla J, Engebretsen L, et al. Biological treatment of the knee with platelet-rich plasma or bone marrow aspirate concentrates: a review of the current status. Acta Orthop. 2017;88:670\u20134. https:\/\/doi.org\/10.1080\/17453674.2017.1368899.","journal-title":"Acta Orthop"},{"key":"4910_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2147\/JPR.S158847","volume":"2018","author":"A Alghadir","year":"2018","unstructured":"Alghadir A, Anwer S, Iqbal A, Iqbal Z. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res. 2018;2018:851\u20136. https:\/\/doi.org\/10.2147\/JPR.S158847.","journal-title":"J Pain Res"},{"key":"4910_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2519\/jospt.1997.26.5.253","volume":"26","author":"KE Roach","year":"1997","unstructured":"Roach KE, Brown MD, Dunigan KM, Kusek CI, Walas M. Test-retest reliability of patient reports of low Back pain. J Orthop Sport Phys Ther. 1997;26:253\u20139. https:\/\/doi.org\/10.2519\/jospt.1997.26.5.253.","journal-title":"J Orthop Sport Phys Ther"},{"key":"4910_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12570-012-0100-3","volume":"3","author":"RBG Brokelman","year":"2012","unstructured":"Brokelman RBG, Haverkamp D, van Loon C, Hol A, van Kampen A, Veth R. The validation of the visual analogue scale for patient satisfaction after total hip arthroplasty. Eur Orthop Traumatol. 2012;3:101\u20135. https:\/\/doi.org\/10.1007\/s12570-012-0100-3.","journal-title":"Eur Orthop Traumatol"},{"key":"4910_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2519\/jospt.1998.28.2.88","volume":"28","author":"EM Roos","year":"1998","unstructured":"Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee injury and osteoarthritis outcome score (KOOS) - development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28:88\u201396. https:\/\/doi.org\/10.2519\/jospt.1998.28.2.88.","journal-title":"J Orthop Sports Phys Ther"},{"key":"4910_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1477-7525-1-64","volume":"1","author":"EM Roos","year":"2003","unstructured":"Roos EM, Lohmander LS. The knee injury and osteoarthritis outcome score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64. https:\/\/doi.org\/10.1186\/1477-7525-1-64.","journal-title":"Health Qual Life Outcomes"},{"key":"4910_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/rheumatology\/30.2.150","volume":"30","author":"N Bellamy","year":"1991","unstructured":"Bellamy N, Goldsmiti CH, Buchanan WW, Campbell J, Duku E. Prior score availability: observations using the WOMAC osteoarthritis index. Rheumatology. 1991;30:150\u20131. https:\/\/doi.org\/10.1093\/rheumatology\/30.2.150.","journal-title":"Rheumatology."},{"key":"4910_CR31","first-page":"1833","volume":"15","author":"N Bellamy","year":"1988","unstructured":"Bellamy N, Buchanan W, Goldsmith C, Campbell J, Stitt L. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833\u201340 https:\/\/pubmed.ncbi.nlm.nih.gov\/3068365\/. Accessed 7 Jan 2021.","journal-title":"J Rheumatol"},{"key":"4910_CR32","unstructured":"Orthopaedic Scores. Knee Injury and Osteopaedic Outcome Score (WOMAC). https:\/\/www.orthopaedicscore.com\/scorepages\/knee_injury_osteopaedic_outcome_score_womac.html. Accessed 28 Feb 2021."},{"key":"4910_CR33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/sctm.18-0285","volume":"8","author":"K Mautner","year":"2019","unstructured":"Mautner K, Bowers R, Easley K, Fausel Z, Robinson R. Functional outcomes following microfragmented adipose tissue versus bone marrow aspirate concentrate injections for symptomatic knee osteoarthritis. Stem Cells Transl Med. 2019;8:1149\u201356. https:\/\/doi.org\/10.1002\/sctm.18-0285.","journal-title":"Stem Cells Transl Med"},{"key":"4910_CR34","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2018.19319","volume":"320","author":"D Gregori","year":"2018","unstructured":"Gregori D, Giacovelli G, Minto C, Barbetta B, Gualtieri F, Azzolina D, et al. Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA - J Am Med Assoc. 2018;320:2564\u201379. https:\/\/doi.org\/10.1001\/jama.2018.19319.","journal-title":"JAMA - J Am Med Assoc"},{"key":"4910_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00871","volume":"4","author":"GS Themistocleous","year":"2018","unstructured":"Themistocleous GS, Chloros GD, Kyrantzoulis IM, Georgokostas IA, Themistocleous MS, Papagelopoulos PJ, et al. Effectiveness of a single intra-articular bone marrow aspirate concentrate (BMAC) injection in patients with grade 3 and 4 knee osteoarthritis. Heliyon. 2018;4:e00871.","journal-title":"Heliyon."},{"key":"4910_CR36","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.apmr.2013.11.006","volume":"95","author":"KV Chang","year":"2014","unstructured":"Chang KV, Hung CY, Aliwarga F, Wang TG, Han DS, Chen WS. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2014;95:562\u201375.","journal-title":"Arch Phys Med Rehabil"},{"key":"4910_CR37","first-page":"1","volume":"8","author":"SA Raeissadat","year":"2015","unstructured":"Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, et al. Knee osteoarthritis injection choices: platelet-rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial). Clin Med Insights Arthr Musculoskelet Disord. 2015;8:1\u20138.","journal-title":"Clin Med Insights Arthr Musculoskelet Disord"},{"key":"4910_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/00913847.2016.1168272","volume":"44","author":"MM Richards","year":"2016","unstructured":"Richards MM, Maxwell JS, Weng L, Angelos MG, Golzarian J. Intra-articular treatment of knee osteoarthritis: from anti-inflammatories to products of regenerative medicine. Phys Sportsmed. 2016;44:101\u20138. https:\/\/doi.org\/10.1080\/00913847.2016.1168272.","journal-title":"Phys Sportsmed"},{"key":"4910_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/0363546520909397","volume":"49","author":"JW Belk","year":"2021","unstructured":"Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and Meta-analysis of randomized controlled trials. Am J Sports Med. 2021;49:249\u201360. https:\/\/doi.org\/10.1177\/0363546520909397.","journal-title":"Am J Sports Med"},{"key":"4910_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.arthro.2020.03.041","volume":"37","author":"SB Han","year":"2021","unstructured":"Han SB, Seo IW, Shin YS. Intra-articular injections of hyaluronic acid or steroids associated with better outcomes than platelet-rich plasma, adipose Mesenchymal stromal cells, or placebo in knee osteoarthritis: a network Meta-analysis. Arthrosc - J Arthrosc Relat Surg. 2021;37:292\u2013306.","journal-title":"Arthrosc - J Arthrosc Relat Surg"},{"key":"4910_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00264-020-04703-w","volume":"45","author":"C Cavallo","year":"2021","unstructured":"Cavallo C, Boffa A, Andriolo L, Silva S, Grigolo B, Zaffagnini S, et al. Bone marrow concentrate injections for the treatment of osteoarthritis: evidence from preclinical findings to the clinical application. Int Orthop. 2021;45:525\u201338. https:\/\/doi.org\/10.1007\/s00264-020-04703-w.","journal-title":"Int Orthop"},{"key":"4910_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/0363546516662455","volume":"45","author":"SA Shapiro","year":"2017","unstructured":"Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O\u2019Connor MI. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2017;45:82\u201390. https:\/\/doi.org\/10.1177\/0363546516662455.","journal-title":"Am J Sports Med"},{"key":"4910_CR43","doi-asserted-by":"publisher","first-page":"232596711990095","DOI":"10.1177\/2325967119900958","volume":"8","author":"AW Anz","year":"2020","unstructured":"Anz AW, Hubbard R, Rendos NK, Everts PA, Andrews JR, Hackel JG. Bone marrow aspirate concentrate is equivalent to platelet-rich plasma for the treatment of knee osteoarthritis at 1 year: a prospective, Randomized Trial. Orthop J Sport Med. 2020;8:2325967119900958. https:\/\/doi.org\/10.1177\/2325967119900958.","journal-title":"Orthop J Sport Med"},{"key":"4910_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/370621","volume":"2014","author":"C Centeno","year":"2014","unstructured":"Centeno C, Pitts J, Al-Sayegh H, Freeman M. Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft. Biomed Res Int. 2014;2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/370621.","journal-title":"Biomed Res Int"},{"key":"4910_CR45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.arthro.2012.11.017","volume":"29","author":"YG Koh","year":"2013","unstructured":"Koh YG, Jo SB, Kwon OR, Suh DS, Lee SW, Park SH, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthrosc - J Arthrosc Relat Surg. 2013;29:748\u201355.","journal-title":"Arthrosc - J Arthrosc Relat Surg"},{"key":"4910_CR46","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.knee.2012.04.001","volume":"19","author":"YG Koh","year":"2012","unstructured":"Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19:902\u20137.","journal-title":"Knee."},{"key":"4910_CR47","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","volume":"33","author":"K Stenderup","year":"2003","unstructured":"Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919\u201326.","journal-title":"Bone."},{"key":"4910_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0736-0266(00)00010-3","volume":"19","author":"GF Muschler","year":"2001","unstructured":"Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001;19:117\u201325.","journal-title":"J Orthop Res"},{"key":"4910_CR49","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/107632702320934010","volume":"8","author":"SC Mendes","year":"2002","unstructured":"Mendes SC, Tibbe JM, Veenhof M, Bakker K, Both S, Platenburg PP, et al. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng. 2002;8:911\u201320. https:\/\/doi.org\/10.1089\/107632702320934010.","journal-title":"Tissue Eng"},{"key":"4910_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1741-7015-11-146","volume":"11","author":"G Siegel","year":"2013","unstructured":"Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Sch\u00e4fer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. 2013;11:146. https:\/\/doi.org\/10.1186\/1741-7015-11-146.","journal-title":"BMC Med"},{"key":"4910_CR51","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/S00264-014-2318-X","volume":"38","author":"P Hernigou","year":"2014","unstructured":"Hernigou P, Desroches A, Queinnec S, Flouzat Lachaniette CH, Poignard A, Allain J, et al. Morbidity of graft harvesting versus bone marrow aspiration in cell regenerative therapy. Int Orthop. 2014;38:1855\u201360. https:\/\/doi.org\/10.1007\/S00264-014-2318-X.","journal-title":"Int Orthop"},{"key":"4910_CR52","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1177\/0363546515582027","volume":"43","author":"G Filardo","year":"2015","unstructured":"Filardo G, Di Matteo B, Di Martino A, Merli ML, Cenacchi A, Fornasari P, et al. Platelet-rich plasma intra-articular knee injections show no superiority versus viscosupplementation: a randomized controlled trial. Am J Sports Med. 2015;43:1575\u201382. https:\/\/doi.org\/10.1177\/0363546515582027.","journal-title":"Am J Sports Med"},{"key":"4910_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/0363546512471299","volume":"41","author":"S Patel","year":"2013","unstructured":"Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41:356\u201364. https:\/\/doi.org\/10.1177\/0363546512471299.","journal-title":"Am J Sports Med"},{"key":"4910_CR54","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1016\/j.arthro.2013.09.006","volume":"29","author":"A Khoshbin","year":"2013","unstructured":"Khoshbin A, Leroux T, Wasserstein D, Marks P, Theodoropoulos J, Ogilvie-Harris D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthrosc - J Arthrosc Relat Surg. 2013;29:2037\u201348. https:\/\/doi.org\/10.1016\/j.arthro.2013.09.006.","journal-title":"Arthrosc - J Arthrosc Relat Surg"},{"key":"4910_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00441-019-02996-x","volume":"376","author":"B O\u2019Connell","year":"2019","unstructured":"O\u2019Connell B, Wragg NM, Wilson SL. The use of PRP injections in the management of knee osteoarthritis. Cell Tissue Res. 2019;376:143\u201352. https:\/\/doi.org\/10.1007\/s00441-019-02996-x.","journal-title":"Cell Tissue Res"},{"key":"4910_CR56","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00167-016-3981-9","volume":"26","author":"JM Cassano","year":"2018","unstructured":"Cassano JM, Kennedy JG, Ross KA, Fraser EJ, Goodale MB, Fortier LA. Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sport Traumatol Arthrosc. 2018;26:333\u201342. https:\/\/doi.org\/10.1007\/s00167-016-3981-9.","journal-title":"Knee Surg Sport Traumatol Arthrosc"},{"key":"4910_CR57","unstructured":"National Library of Medicine. The comparison of knee osteoarthritis treatment with bone marrow aspirate concentrate, leukocyte rich platelet rich plasma and hyaluronic acid. 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03825133?cond=Osteo+Arthritis+Knee&intr=BMAC%2FPRP&draw=2&rank=3. Accessed 6 Jan 2021."},{"key":"4910_CR58","unstructured":"National Library of Medicine. mesenchymal stem cells enhanced with PRP versus PRP in OA knee. 2013. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01985633. Accessed 6 Jan 2021."},{"key":"4910_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ctcp.2018.11.005","volume":"34","author":"V Suba\u015f\u0131","year":"2019","unstructured":"Suba\u015f\u0131 V, Ekiz T. Bone marrow aspiration concentrate and platelet-rich plasma in the treatment of knee osteoarthritis: a report of three cases. Complement Ther Clin Pract. 2019;34:113\u20135. https:\/\/doi.org\/10.1016\/j.ctcp.2018.11.005.","journal-title":"Complement Ther Clin Pract"},{"key":"4910_CR60","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2217\/rme-2016-0081","volume":"11","author":"S Sampson","year":"2016","unstructured":"Sampson S, Smith J, Vincent H, Aufiero D, Zall M, Botto-Van-Bemden A. Intra-articular bone marrow concentrate injection protocol: short-term efficacy in osteoarthritis. Regen Med. 2016;11:511\u201320. https:\/\/doi.org\/10.2217\/rme-2016-0081.","journal-title":"Regen Med"},{"key":"4910_CR61","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1038\/s41598-019-43700-x","volume":"9","author":"S Laner-Plamberger","year":"2019","unstructured":"Laner-Plamberger S, Oeller M, Poupardin R, Krisch L, Hochmann S, Kalathur R, et al. Heparin differentially impacts gene expression of stromal cells from various tissues. Sci Rep. 2019;9:7258. https:\/\/doi.org\/10.1038\/s41598-019-43700-x.","journal-title":"Sci Rep"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04910-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04910-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04910-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T17:07:05Z","timestamp":1641229625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04910-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4910"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04910-5","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"11 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective comparative study involving human participants was conducted according to the World Medical Association Declaration of Helsinki. Conforming with the local legislative and procedural institutional obligations at the Canadian Centres for Regenerative Therapy (CCRT, Toronto ON) concerning the study nature, ethical review and approval by the institutional ethics committee was not mandated. Informed consent forms as a written expression of patient voluntary participation were obtained. Patients also consented in writing to the anonymous publishing of collected data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}